Literature DB >> 8572306

Surface plasmon resonance detection and multispot sensing for direct monitoring of interactions involving low-molecular-weight analytes and for determination of low affinities.

R Karlsson1, R Ståhlberg.   

Abstract

Surface plasmon resonance detection allows direct observation of molecular interactions between an analyte in solution and its immobilized binding partner. The use of simultaneous monitoring of interaction events on multiple sensing surfaces, with varying amounts of immobilized receptor, for detection of low-molecular-weight analytes and for determination of low affinities was investigated. Using multispot sensing and BIAcore 2000 instrumentation, analytes as small as 180 Da were detected and affinities in the 50 microM range could be determined. The use of multispot sensing thus extends direct interaction analysis to include low-molecular-weight analytes and low-affinity interactions.

Mesh:

Substances:

Year:  1995        PMID: 8572306     DOI: 10.1006/abio.1995.1350

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  Multiplexed DNA quantification by spectroscopic shift of two microsphere cavities.

Authors:  Frank Vollmer; Stephen Arnold; Dieter Braun; Iwao Teraoka; Albert Libchaber
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

2.  Biointeraction analysis of immobilized antibodies and related agents by high-performance immunoaffinity chromatography.

Authors:  Erika Pfaunmiller; Annette C Moser; David S Hage
Journal:  Methods       Date:  2011-09-01       Impact factor: 3.608

3.  Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae.

Authors:  L A Novotny; J A Jurcisek; M E Pichichero; L O Bakaletz
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Basal transcription factors TBP and TFIIB and the viral coactivator E1A 13S bind with distinct affinities and kinetics to the transactivation domain of NF-kappaB p65.

Authors:  K Paal; P A Baeuerle; M L Schmitz
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

5.  Drug binding assays do not reveal specific binding of lacosamide to collapsin response mediator protein 2 (CRMP-2).

Authors:  Christian Wolff; Bruce Carrington; Michel Varrin-Doyer; Anne Vandendriessche; Christy Van der Perren; Michel Famelart; Michel Gillard; Patrik Foerch; Véronique Rogemond; Jerôme Honnorat; Alastair Lawson; Karen Miller
Journal:  CNS Neurosci Ther       Date:  2012-06       Impact factor: 5.243

Review 6.  Kinetic studies of biological interactions by affinity chromatography.

Authors:  John E Schiel; David S Hage
Journal:  J Sep Sci       Date:  2009-05       Impact factor: 3.645

7.  Biointeraction analysis by high-performance affinity chromatography: Kinetic studies of immobilized antibodies.

Authors:  Mary Anne Nelson; Annette Moser; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-04-08       Impact factor: 3.205

8.  Microcantilever-Based Label-Free Characterization of Temperature-Dependent Biomolecular Affinity Binding.

Authors:  Bin Wang; Fengliang Huang; Thaihuu Nguyen; Yong Xu; Qiao Lin
Journal:  Sens Actuators B Chem       Date:  2013-01-01       Impact factor: 7.460

9.  Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.

Authors:  Lei Wang; Yang Yu; Dar-Chone Chow; Fei Yan; Chih-Chao Hsu; Fabio Stossi; Michael A Mancini; Timothy Palzkill; Lan Liao; Suoling Zhou; Jianming Xu; David M Lonard; Bert W O'Malley
Journal:  Cancer Cell       Date:  2015-08-10       Impact factor: 31.743

10.  The contribution of conformational adjustments and long-range electrostatic forces to the CD2/CD58 interaction.

Authors:  Alice Kearney; Adam Avramovic; Mónica A A Castro; Alexandre M Carmo; Simon J Davis; P Anton van der Merwe
Journal:  J Biol Chem       Date:  2007-03-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.